PRPH ProPhase Labs Inc

USD 0.34 -0.02 ( -5.10%)
Icon

ProPhase Labs Inc (PRPH) Financial Statements

COMMON STOCK | Diagnostics & Research | NSD
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 0.34

-0.02 (-5.10%)

USD 0.01B

0.43M

USD -1.00

USD 10.00 (+2883.29%)

Icon

PRPH

ProPhase Labs Inc (USD)
COMMON STOCK | NSD
USD 0.34
-0.02 ( -5.10%)

ProPhase Labs Inc (PRPH) Annual Income Statement (USD)

PRPH Quarterly Financials (USD)

Frequently Asked Questions About ProPhase Labs Inc (PRPH) Stock

ProPhase Labs Inc's (PRPH) last reported annual revenue was USD 6.77 Million.

ProPhase Labs Inc's (PRPH) annual revenue growth rate based on the revenue reported in the past 5 years is : -7.27%

ProPhase Labs Inc's(PRPH) is not profitable as of its last reported annual financials.

The net profit margin for ProPhase Labs Inc's(PRPH) from its laster reported year is -788.24%

The return on equity (ROE) for ProPhase Labs Inc's(PRPH) from its last reported annual financials is : -174.58%

The return on assets (ROA) for ProPhase Labs Inc's(PRPH) from its last reported annual financials is : -31.13%

The return on invested capital (ROIC) for ProPhase Labs Inc's(PRPH) from its last reported annual financials is : -138.59%

The Debt to Equity ratio for ProPhase Labs Inc's(PRPH) from its last reported annual financials is : 158.47%

The dividend yield for ProPhase Labs Inc's(PRPH) from its laster reported year is 0.00%

ProPhase Labs Inc's(PRPH) has negative cash flow as of its last reported annual financials.

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...